Overview

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Status:
Active, not recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
A multi-center adaptive randomized placebo-controlled platform trial evaluating the efficacy and safety of anti-thrombotic strategies in COVID-19 adults not requiring hospitalization at time of diagnosis
Phase:
Phase 3
Details
Lead Sponsor:
Frank C Sciurba
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Apixaban
Aspirin